

Bacterial pathogenicity deeply depends on the ability to secrete virulence factors that bind specific targets on host cells and manipulate host responses. The Gram-positive bacterium Listeria monocytogenes is a human foodborne pathogen that remains a serious public health concern. To transport proteins across its cell envelope, this facultative intracellular pathogen engages a set of specialized secretion systems. Here we show that L. monocytogenes EGDe uses a specialized secretion system, named ESX-1, to secrete EsxA, a homolog of the virulence determinants ESAT-6 and EsxA of Mycobacterium tuberculosis and Staphylococcus aureus, respectively. Our data show that the L. monocytogenes ESX-1 secretion system and its substrates are dispensable for bacterial invasion and intracellular multiplication in eukaryotic cell lines. Surprisingly, we found that the EssCdependent secretion of EsxA has a detrimental effect on L. monocytogenes in vivo infection. © 2017 Taylor & Francis.
| EMTREE drug terms: | virulence factorbacterial antigenbacterial proteinESAT-6 protein, Mycobacterium tuberculosis |
|---|---|
| EMTREE medical terms: | animal experimentanimal modelanimal tissueArticlebacterial countbacterial growthbacterial virulencebioinformaticscell invasion assaycontrolled studyDNA sequencefemalegene expressiongene overexpressiongenetic complementationgrowth curveimmune responseListeria monocytogeneslisteriosismouseMycobacterium tuberculosisnonhumanpolyacrylamide gel electrophoresisreverse transcription polymerase chain reactionsequence homologyStaphylococcus aureustype VII secretion systemWestern blottingwhole genome sequencingbacterial secretion systemcell linegeneticsgrowth, development and aginghumanmetabolismpathogenicity |
| MeSH: | Antigens, BacterialBacterial ProteinsBacterial Secretion SystemsCell LineHumansListeria monocytogenesMycobacterium tuberculosisStaphylococcus aureusVirulence Factors |
Antigens, Bacterial; Bacterial Proteins; Bacterial Secretion Systems; ESAT-6 protein, Mycobacterium tuberculosis; Virulence Factors
| Funding sponsor | Funding number | Acronym |
|---|---|---|
| Programa Operacional Temático Factores de Competitividade | BIO2013-46281-P,BIO2014-55238-R | |
| Federación Española de Enfermedades Raras | Infect-ERA/0001/2013 PROANTILIS,SFRH/BD/61825/ 2009,4293,SFRH/BD/ 28185/2006,SFRH/BD/86871/2012 | FEDER |
This work was supported for the DC lab by national funds through FCT - Funda?ao para a Ciencia e a Tecnologia/MEC - Ministerio da Educa?ao e Ciencia and co-funded by FEDER funds within the partnership agreement PT2020 related with the research unit number 4293, and within the research project Infect-ERA/0001/2013 PROANTILIS. O.R., J.P. and F.C. were supported by doctoral fellowships from FCT (SFRH/BD/ 28185/2006, SFRH/BD/86871/2012 and SFRH/BD/61825/ 2009), L.M. by the Santander International Mobility Program and SS by FCT Investigator program (COMPETE, POPH, and FCT). This work was supported for the F.G.-dP. lab by grants BIO2014-55238-R (to M.G.P.) and BIO2013-46281-P (to F.G.-dP.) from the Spanish Ministry of Economy and Competitiveness.
Cabanes, D.; I3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto IBMC - Institute for Molecular and Cell Biology, GM2 - Group of Molecular Microbiology, Rua Alfredo Allen, 208, Porto, Portugal;
© Copyright 2018 Elsevier B.V., All rights reserved.